Ensurge Micropower ASA - Extraordinary General Meeting held on 3 December 2025
Rhea-AI Summary
Ensurge Micropower (OSE: ENMPY) held an Extraordinary General Meeting on 3 December 2025 as an electronic meeting.
The meeting approved the issuance of 27,433,079 tranche 2 shares from the private placement announced 9 November 2025, a subsequent offering of up to 22,222,222 offer shares to existing shareholders, and the issuance of 67,934,000 warrants to Corning Research & Development Corporation with an exercise price of NOK 1.50. Minutes will be posted on the company website.
Positive
- Tranche 2 shares issued: 27,433,079 approved
- Offer shares reserved: up to 22,222,222 for existing shareholders
- Warrants granted: 67,934,000 to Corning R&D at NOK 1.50
Negative
- Immediate dilution: 27,433,079 new tranche 2 shares
- Further dilution possible: up to 22,222,222 offer shares
- Potential dilution from warrants: 67,934,000 exercisable at NOK 1.50
Oslo, 3 December 2025
An Extraordinary General Meeting in Ensurge Micropower ASA (the "Company") was held today as an electronic meeting. All items on the agenda were adopted in accordance with the proposals of the Board of Directors in the notice to the Extraordinary General Meeting, including, among other things, the issuance of 27,433,079 tranche 2 shares in the private placement announced on 9 November 2025, a subsequent offering of up to 22,222,222 offer shares to existing shareholders not participating in such private placement (more details to follow in a separate stock exchange announcement), and the issuance of 67,934,000 warrants to Corning Research & Development Corporation, each warrant with an exercise price of NOK 1.50.
The minutes from the Extraordinary General Meeting will be made available on the Company's website.
About Ensurge Micropower:
Ensurge (www.ensurge.com) powers the future of AI-enabled devices with advanced microbattery technology that delivers unmatched performance and safety. From its base in San Jose, California, the Company's team of battery specialists have pioneered thin-film batteries produced on high-precision roll-to-roll production processes. These innovations enable new possibilities in form-factor-constrained applications across consumer, medical, and industrial markets. Ensurge partners with leading global customers to accelerate their products to market and is listed on the Oslo Stock Exchange. For more news and information on Ensurge, please visit https://www.ensurge.com/news-room.
For more information, please contact:
Shauna McIntyre - Chief Executive Officer E- mail: shauna.mcintyre@ensurge.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.